# |
Query |
Results |
S57 |
S44 AND S56 |
329 |
S56 |
S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 |
1,348,419 |
S55 |
TX allocat* random* |
10,952 |
S54 |
(MH "Quantitative Studies") |
23,227 |
S53 |
(MH "Placebos") |
11,446 |
S52 |
TX placebo* |
58,971 |
S51 |
TX random* allocat* |
10,952 |
S50 |
(MH "Random Assignment") |
56,376 |
S49 |
TX randomi* control* trial* |
174,775 |
S48 |
TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) |
1,030,939 |
S47 |
TX clinic* n1 trial* |
250,159 |
S46 |
PT Clinical trial |
86,851 |
S45 |
(MH "Clinical Trials+") |
266,213 |
S44 |
S31 AND S43 |
2,527 |
S43 |
S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 |
42,195 |
S42 |
TX recurrent pregnancy loss* |
659 |
S41 |
TX (advanced N2 age*) |
4,923 |
S40 |
TX recurrent miscarriage* |
557 |
S39 |
TX recurrent implantation failure* |
249 |
S38 |
TX pregnancy fail* |
7,850 |
S37 |
TX poor implantation* |
922 |
S36 |
TX (ivf or ICSI) |
4,828 |
S35 |
TX in vitro fertili?ation |
6,852 |
S34 |
TX (embryo* or blastocyst* or blastomer*) |
23,319 |
S33 |
TX intracytoplasmic sperm injection* |
866 |
S32 |
(MM "Fertilization in Vitro") |
3,354 |
S31 |
S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 |
54,932 |
S30 |
TX (Pre implant* N3 test*) |
202 |
S29 |
TX (Pre implant* N3 diagnos*) |
121 |
S28 |
TX (Pre implant* N3 screen*) |
50 |
S27 |
TX (spent culture medi*) |
705 |
S26 |
TX (trophectoderm N3 biops*) |
102 |
S25 |
TX (polar body N3 biops*) |
8 |
S24 |
TX Next generation sequenc* |
3,502 |
S23 |
TX WGA |
101 |
S22 |
TX whole genome amplification* |
154 |
S21 |
TX Nucleic Acid Amplification Technique* |
1,436 |
S20 |
(MM "Nucleic Acid Amplification Techniques+") |
3,510 |
S19 |
TX single nucleotide polymorphism |
8,513 |
S18 |
(MM "Polymorphism, Genetic") |
14,077 |
S17 |
Polymorphism, Single Nucleotide |
8,444 |
S16 |
TX (qPCR or SNP) |
9,861 |
S15 |
TX Quantitative Polymerase |
7,315 |
S14 |
(MM "Polymerase Chain Reaction+") |
3,016 |
S13 |
TX aCGH |
174 |
S12 |
TX CGH |
465 |
S11 |
TX (genom* N2 hybridi?ation) |
667 |
S10 |
(MM "Nucleic Acid Hybridization") |
83 |
S9 |
TX (gene* N2 screen*) |
14,852 |
S8 |
TX (Preimplant* N2 screen*) |
202 |
S7 |
TX Preimplant* Diagnos* |
896 |
S6 |
(MM "In Situ Hybridization+") OR (MM "In Situ Hybridization, Fluorescence+") |
450 |
S5 |
TX (PGS or PGD‐AS) |
1,296 |
S4 |
TX aneuploid* |
2,332 |
S3 |
TX (Preimplant* N3 gene*) |
758 |
S2 |
(MM "Aneuploidy") |
615 |
S1 |
(MM "Preimplantation Diagnosis") |
500 |